 | Up a level |
2016
Hermine, Olivier 
ORCID: 0000-0003-2574-3874, Hoster, Eva ORCID: 0000-0002-0749-1389, Walewski, Jan ORCID: 0000-0003-4247-2674, Bosly, Andre, Stilgenbauer, Stephan, Thieblemont, Catherine ORCID: 0000-0002-9941-2448, Szymczyk, Michal, Bouabdallah, Reda, Kneba, Michael, Hallek, Michael, Salles, Gilles ORCID: 0000-0002-9541-8666, Feugier, Pierre, Ribrag, Vincent, Birkmann, Josef, Forstpointner, Roswitha, Haioun, Corinne, Haenel, Mathias, Casasnovas, Rene Olivier, Finke, Juergen, Peter, Norma, Bouabdallah, Kamal, Sebban, Catherine, Fischer, Thomas, Duehrsen, Ulrich, Metzner, Bernd, Maschmeyer, Georg, Kanz, Lothar, Schmidt, Christian, Delarue, Richard, Brousse, Nicole, Klapper, Wolfram, Macintyre, Elizabeth, Delfau-Larue, Marie-Helene, Pott, Christiane, Hiddemann, Wolfgang, Unterhalt, Michael and Dreyling, Martin
(2016).
Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network.
Lancet, 388 (10044).
S. 565 - 576.
NEW YORK:
ELSEVIER SCIENCE INC.
ISSN 1474-547X
Hoster, Eva ORCID: 0000-0002-0749-1389, Rosenwald, Andreas, Berger, Francoise, Bernd, Heinz-Wolfram, Hartmann, Sylvia, Loddenkemper, Christoph, Barth, Thomas F. E., Brousse, Nicole, Pileri, Stefano, Rymkiewicz, Grzegorz ORCID: 0000-0002-3478-8014, Kodet, Roman, Stilgenbauer, Stephan, Forstpointner, Roswitha, Thieblemont, Catherine ORCID: 0000-0002-9941-2448, Hallek, Michael, Coiffier, Bertrand, Vehling-Kaiser, Ursula, Bouabdallah, Reda, Kanz, Lothar, Pfreundschuh, Michael, Schmidt, Christian, Ribrag, Vincent, Hiddemann, Wolfgang, Unterhalt, Michael, Kluin-Nelemans, Johanna C., Hermine, Olivier ORCID: 0000-0003-2574-3874, Dreyling, Martin H. and Klapper, Wolfram
(2016).
Prognostic Value of Ki-67 Index, Cytology, and Growth Pattern in Mantle-Cell Lymphoma: Results From Randomized Trials of the European Mantle Cell Lymphoma Network.
J. Clin. Oncol., 34 (12).
S. 1386 - 1396.
ALEXANDRIA:
AMER SOC CLINICAL ONCOLOGY.
ISSN 1527-7755
2014
Cartron, Guillaume ORCID: 0000-0003-0659-9635, de Guibert, Sophie, Dilhuydy, Marie-Sarah, Morschhauser, Franck, Leblond, Veronique, Dupuis, Jehan, Mahe, Beatrice, Bouabdallah, Reda, Lei, Guiyuan, Wenger, Michael, Wassner-Fritsch, Elisabeth and Hallek, Michael
(2014).
Obinutuzumab (GA101) in relapsed/refractory chronic lymphocytic leukemia: final data from the phase 1/2 GAUGUIN study.
Blood, 124 (14).
S. 2196 - 2203.
WASHINGTON:
AMER SOC HEMATOLOGY.
ISSN 1528-0020
2012
Hermine, Olivier, Hoster, Eva, Walewski, Jan, Ribrag, Vincent, Brousse, Nicole, Thieblemont, Catherine ORCID: 0000-0002-9941-2448, Bouabdallah, Reda, Dohner, Hartrnut, Feugier, Pierre, Forspointner, Roswitha, Haioun, Corinne, Kneba, Michael, Haenel, Mathias, Casasnovas, Olivier, Mertelsmann, Roland H., Hallek, Michael, Bosly, Andre, Nowacki, M., Klapper, Wolfram, Gisselbrecht, Christian, Coiffier, Bertrand, Unterhalt, Michael, Hiddemann, Wolfgang and Dreyling, Martin H.
(2012).
Alternating Courses of 3x CHOP and 3x DHAP Plus Rituximab Followed by a High Dose ARA-C Containing Myeloablative Regimen and Autologous Stem Cell Transplantation (ASCT) Increases Overall Survival When Compared to 6 Courses of CHOP Plus Rituximab Followed by Myeloablative Radiochemotherapy and ASCT in Mantle Cell Lymphoma: Final Analysis of the MCL Younger Trial of the European Mantle Cell Lymphoma Network (MCL net).
Blood, 120 (21).
WASHINGTON:
AMER SOC HEMATOLOGY.
ISSN 0006-4971